Celanese (CE)
(Delayed Data from NYSE)
$126.90 USD
-3.19 (-2.45%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $126.91 +0.01 (0.01%) 5:20 PM ET
5-Strong Sell of 5 5
B Value C Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Celanese Corporation [CE]
Reports for Purchase
Showing records 141 - 160 ( 477 total )
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 2Q21 Preview - Earnings Could Be a Positive Catalyst for the Sector, in Our View
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Santoprene Acquisition Additive to Value; Raising 2021 Estimates on Acetyls
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
1Q Follow Up: Near-Term Setup Likely Needs M&A to Drive Further Upside
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
1Q21 First Look - ''21 Guide Raised Again; Beating in Specialties and Commodity Acetyls
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: Expect Further Upside to Chemicals in 2021; Upgrade WLK to Overweight
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Strong Outlook Following 2021 Investor Day; We Raise Our Price Target to $183
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Guiding Higher on Strong Acetyls, EM Demand; Organic Expansions Pick Up Pace, a Positive, in Our View
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department